Logo image of KRO

KRONOS WORLDWIDE INC (KRO) Stock Fundamental Analysis

USA - NYSE:KRO - US50105F1057 - Common Stock

6.03 USD
-0.2 (-3.21%)
Last: 9/17/2025, 8:04:00 PM
6.05 USD
+0.02 (+0.33%)
After Hours: 9/17/2025, 8:04:00 PM
Fundamental Rating

4

Overall KRO gets a fundamental rating of 4 out of 10. We evaluated KRO against 83 industry peers in the Chemicals industry. Both the profitability and the financial health of KRO get a neutral evaluation. Nothing too spectacular is happening here. KRO has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

KRO had positive earnings in the past year.
In the past year KRO has reported a negative cash flow from operations.
Of the past 5 years KRO 4 years were profitable.
Each year in the past 5 years KRO had a positive operating cash flow.
KRO Yearly Net Income VS EBIT VS OCF VS FCFKRO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M 300M

1.2 Ratios

KRO's Return On Assets of 3.48% is fine compared to the rest of the industry. KRO outperforms 69.88% of its industry peers.
Looking at the Return On Equity, with a value of 7.97%, KRO is in the better half of the industry, outperforming 72.29% of the companies in the same industry.
KRO has a Return On Invested Capital of 5.53%. This is in the better half of the industry: KRO outperforms 62.65% of its industry peers.
Industry RankSector Rank
ROA 3.48%
ROE 7.97%
ROIC 5.53%
ROA(3y)2.41%
ROA(5y)3.2%
ROE(3y)5.13%
ROE(5y)7.28%
ROIC(3y)N/A
ROIC(5y)N/A
KRO Yearly ROA, ROE, ROICKRO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

1.3 Margins

KRO has a better Profit Margin (3.57%) than 63.86% of its industry peers.
In the last couple of years the Profit Margin of KRO has declined.
The Operating Margin of KRO (5.74%) is worse than 60.24% of its industry peers.
KRO's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 18.88%, KRO is doing worse than 67.47% of the companies in the same industry.
KRO's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 5.74%
PM (TTM) 3.57%
GM 18.88%
OM growth 3Y-12.41%
OM growth 5Y-5.03%
PM growth 3Y-7.77%
PM growth 5Y-1.91%
GM growth 3Y-6.11%
GM growth 5Y-3.12%
KRO Yearly Profit, Operating, Gross MarginsKRO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 30

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), KRO is destroying value.
Compared to 1 year ago, KRO has about the same amount of shares outstanding.
The number of shares outstanding for KRO has been reduced compared to 5 years ago.
KRO has a worse debt/assets ratio than last year.
KRO Yearly Shares OutstandingKRO Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
KRO Yearly Total Debt VS Total AssetsKRO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

An Altman-Z score of 1.82 indicates that KRO is not a great score, but indicates only limited risk for bankruptcy at the moment.
KRO has a Altman-Z score of 1.82. This is comparable to the rest of the industry: KRO outperforms 50.60% of its industry peers.
KRO has a Debt/Equity ratio of 0.59. This is a neutral value indicating KRO is somewhat dependend on debt financing.
With a decent Debt to Equity ratio value of 0.59, KRO is doing good in the industry, outperforming 62.65% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.59
Debt/FCF N/A
Altman-Z 1.82
ROIC/WACC0.59
WACC9.45%
KRO Yearly LT Debt VS Equity VS FCFKRO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M

2.3 Liquidity

A Current Ratio of 2.79 indicates that KRO has no problem at all paying its short term obligations.
KRO has a better Current ratio (2.79) than 77.11% of its industry peers.
KRO has a Quick Ratio of 1.04. This is a normal value and indicates that KRO is financially healthy and should not expect problems in meeting its short term obligations.
With a Quick ratio value of 1.04, KRO is not doing good in the industry: 66.27% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 2.79
Quick Ratio 1.04
KRO Yearly Current Assets VS Current LiabilitesKRO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

5

3. Growth

3.1 Past

KRO shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 100.00%, which is quite impressive.
The earnings per share for KRO have been decreasing by -24.83% on average. This is quite bad
Looking at the last year, KRO shows a small growth in Revenue. The Revenue has grown by 6.51% in the last year.
The Revenue has been growing slightly by 1.74% on average over the past years.
EPS 1Y (TTM)100%
EPS 3Y-43.16%
EPS 5Y-24.83%
EPS Q2Q%-147.06%
Revenue 1Y (TTM)6.51%
Revenue growth 3Y-0.91%
Revenue growth 5Y1.74%
Sales Q2Q%-1.22%

3.2 Future

Based on estimates for the next years, KRO will show a very strong growth in Earnings Per Share. The EPS will grow by 87.51% on average per year.
Based on estimates for the next years, KRO will show a small growth in Revenue. The Revenue will grow by 3.13% on average per year.
EPS Next Y239.47%
EPS Next 2Y129.05%
EPS Next 3Y87.51%
EPS Next 5YN/A
Revenue Next Year-5.58%
Revenue Next 2Y1.14%
Revenue Next 3Y3.13%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
KRO Yearly Revenue VS EstimatesKRO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B 2B
KRO Yearly EPS VS EstimatesKRO Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.5 -0.5 1 1.5

4

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 301.50 indicates a quite expensive valuation of KRO.
Based on the Price/Earnings ratio, KRO is valued a bit more expensive than the industry average as 68.67% of the companies are valued more cheaply.
KRO's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.20.
A Price/Forward Earnings ratio of 6.39 indicates a rather cheap valuation of KRO.
KRO's Price/Forward Earnings ratio is rather cheap when compared to the industry. KRO is cheaper than 93.98% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.70. KRO is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 301.5
Fwd PE 6.39
KRO Price Earnings VS Forward Price EarningsKRO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 100 200 300

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, KRO is valued a bit cheaper than 79.52% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 7.32
KRO Per share dataKRO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

KRO's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
A more expensive valuation may be justified as KRO's earnings are expected to grow with 87.51% in the coming years.
PEG (NY)1.26
PEG (5Y)N/A
EPS Next 2Y129.05%
EPS Next 3Y87.51%

5

5. Dividend

5.1 Amount

KRO has a Yearly Dividend Yield of 3.18%. Purely for dividend investing, there may be better candidates out there.
KRO's Dividend Yield is rather good when compared to the industry average which is at 3.43. KRO pays more dividend than 80.72% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.38, KRO pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 3.18%

5.2 History

The dividend of KRO decreases each year by -7.80%.
KRO has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)-7.8%
Div Incr Years0
Div Non Decr Years0
KRO Yearly Dividends per shareKRO Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6

5.3 Sustainability

KRO pays out 34.07% of its income as dividend. This is a sustainable payout ratio.
DP34.07%
EPS Next 2Y129.05%
EPS Next 3Y87.51%
KRO Yearly Income VS Free CF VS DividendKRO Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M 300M
KRO Dividend Payout.KRO Dividend Payout, showing the Payout Ratio.KRO Dividend Payout.PayoutRetained Earnings

KRONOS WORLDWIDE INC

NYSE:KRO (9/17/2025, 8:04:00 PM)

After market: 6.05 +0.02 (+0.33%)

6.03

-0.2 (-3.21%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)08-06 2025-08-06/amc
Earnings (Next)11-04 2025-11-04/amc
Inst Owners16.93%
Inst Owner Change-2.66%
Ins Owners0.14%
Ins Owner Change0.12%
Market Cap693.75M
Analysts46.67
Price Target8.16 (35.32%)
Short Float %6.71%
Short Ratio4
Dividend
Industry RankSector Rank
Dividend Yield 3.18%
Yearly Dividend0.48
Dividend Growth(5Y)-7.8%
DP34.07%
Div Incr Years0
Div Non Decr Years0
Ex-Date09-05 2025-09-05 (0.05)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-82.74%
Min EPS beat(2)-158.67%
Max EPS beat(2)-6.81%
EPS beat(4)0
Avg EPS beat(4)-107.62%
Min EPS beat(4)-188.88%
Max EPS beat(4)-6.81%
EPS beat(8)3
Avg EPS beat(8)28.83%
EPS beat(12)4
Avg EPS beat(12)-22.07%
EPS beat(16)7
Avg EPS beat(16)-10.9%
Revenue beat(2)0
Avg Revenue beat(2)-3.15%
Min Revenue beat(2)-3.28%
Max Revenue beat(2)-3.02%
Revenue beat(4)0
Avg Revenue beat(4)-9.32%
Min Revenue beat(4)-15.74%
Max Revenue beat(4)-3.02%
Revenue beat(8)2
Avg Revenue beat(8)-4.84%
Revenue beat(12)4
Avg Revenue beat(12)-3.11%
Revenue beat(16)7
Avg Revenue beat(16)-1.55%
PT rev (1m)0%
PT rev (3m)-2.04%
EPS NQ rev (1m)-57.14%
EPS NQ rev (3m)-65.33%
EPS NY rev (1m)-23.42%
EPS NY rev (3m)-23.42%
Revenue NQ rev (1m)-0.52%
Revenue NQ rev (3m)-4.77%
Revenue NY rev (1m)-0.85%
Revenue NY rev (3m)-3.27%
Valuation
Industry RankSector Rank
PE 301.5
Fwd PE 6.39
P/S 0.37
P/FCF N/A
P/OCF N/A
P/B 0.82
P/tB 0.82
EV/EBITDA 7.32
EPS(TTM)0.02
EY0.33%
EPS(NY)0.94
Fwd EY15.66%
FCF(TTM)-0.42
FCFYN/A
OCF(TTM)-0.04
OCFYN/A
SpS16.45
BVpS7.36
TBVpS7.34
PEG (NY)1.26
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3.48%
ROE 7.97%
ROCE 7.01%
ROIC 5.53%
ROICexc 5.6%
ROICexgc 5.61%
OM 5.74%
PM (TTM) 3.57%
GM 18.88%
FCFM N/A
ROA(3y)2.41%
ROA(5y)3.2%
ROE(3y)5.13%
ROE(5y)7.28%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y-13.41%
ROICexcg growth 5Y-3.71%
ROICexc growth 3Y-13.47%
ROICexc growth 5Y-3.75%
OM growth 3Y-12.41%
OM growth 5Y-5.03%
PM growth 3Y-7.77%
PM growth 5Y-1.91%
GM growth 3Y-6.11%
GM growth 5Y-3.12%
F-Score3
Asset Turnover0.98
Health
Industry RankSector Rank
Debt/Equity 0.59
Debt/FCF N/A
Debt/EBITDA 2.9
Cap/Depr 69.69%
Cap/Sales 2.36%
Interest Coverage 2.04
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.79
Quick Ratio 1.04
Altman-Z 1.82
F-Score3
WACC9.45%
ROIC/WACC0.59
Cap/Depr(3y)85.77%
Cap/Depr(5y)95.93%
Cap/Sales(3y)2.56%
Cap/Sales(5y)2.91%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)100%
EPS 3Y-43.16%
EPS 5Y-24.83%
EPS Q2Q%-147.06%
EPS Next Y239.47%
EPS Next 2Y129.05%
EPS Next 3Y87.51%
EPS Next 5YN/A
Revenue 1Y (TTM)6.51%
Revenue growth 3Y-0.91%
Revenue growth 5Y1.74%
Sales Q2Q%-1.22%
Revenue Next Year-5.58%
Revenue Next 2Y1.14%
Revenue Next 3Y3.13%
Revenue Next 5YN/A
EBIT growth 1Y271.92%
EBIT growth 3Y-13.2%
EBIT growth 5Y-3.37%
EBIT Next Year44.25%
EBIT Next 3Y25.84%
EBIT Next 5YN/A
FCF growth 1Y56.05%
FCF growth 3Y-33.75%
FCF growth 5Y-16.38%
OCF growth 1Y90.72%
OCF growth 3Y-29.45%
OCF growth 5Y-14.67%